Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani

Clin Mol Hepatol. 2023;29(1):135-145. Published online September 5, 2022

DOI: https://doi.org/10.3350/cmh.2022.0181

View: 2258 Download: 216 Citations: 4

Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly

Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun

Clin Mol Hepatol. 2023;29(1):120-134. Published online August 12, 2022

DOI: https://doi.org/10.3350/cmh.2021.0395

View: 1556 Download: 127 Citations: 2

Editorial

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?

Young-Suk Lim

Clin Mol Hepatol. 2023;29(1):118-119. Published online November 29, 2022

DOI: https://doi.org/10.3350/cmh.2022.0413

View: 864 Download: 90

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers

Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip

Clin Mol Hepatol. 2023;29(1):113-117. Published online October 31, 2022

DOI: https://doi.org/10.3350/cmh.2022.0333

View: 1062 Download: 67 Citations: 2

Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey

Susana G Rodrigues

Clin Mol Hepatol. 2023;29(1):110-112. Published online December 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0414

View: 923 Download: 49

Non-invasive tests-based risk stratification: Baveno VII and beyond

Georg Semmler, Mathias Jachs, Mattias Mandorfer

Clin Mol Hepatol. 2023;29(1):105-109. Published online November 23, 2022

DOI: https://doi.org/10.3350/cmh.2022.0361

View: 1096 Download: 60 Citation: 1

The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus

Jeong-Ju Yoo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(1):102-104. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0353

View: 947 Download: 84

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(1):99-101. Published online October 27, 2022

DOI: https://doi.org/10.3350/cmh.2022.0321

View: 1012 Download: 47

Review

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin

Clin Mol Hepatol. 2023;29(1):77-98. Published online October 13, 2022

DOI: https://doi.org/10.3350/cmh.2022.0237

View: 2718 Download: 329 Citations: 2

Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment

Soo-Jeung Park, Young S. Hahn

Clin Mol Hepatol. 2023;29(1):65-76. Published online August 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0032

View: 2112 Download: 122 Citations: 3

Development and prognosis of hepatocellular carcinoma in patients with diabetes

Takuma Nakatsuka, Ryosuke Tateishi

Clin Mol Hepatol. 2023;29(1):51-64. Published online July 29, 2022

DOI: https://doi.org/10.3350/cmh.2022.0095

View: 1872 Download: 155 Citations: 2

Wnt signaling in liver regeneration, disease, and cancer

Gengyi Zou, Jae-Il Park

Clin Mol Hepatol. 2023;29(1):33-50. Published online July 4, 2022

DOI: https://doi.org/10.3350/cmh.2022.0058

View: 2137 Download: 147

Management of refractory ascites

Florence Wong

Clin Mol Hepatol. 2023;29(1):16-32. Published online June 9, 2022

DOI: https://doi.org/10.3350/cmh.2022.0104

View: 2476 Download: 395

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection

Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller

Clin Mol Hepatol. 2023;29(1):1-15. Published online April 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0017

View: 6121 Download: 123

Erratum

Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]

Clin Mol Hepatol. 2022;28(4):940-940. Published online September 7, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084.e1
Corrects: Clin Mol Hepatol 2022;28(2):276

View: 1149 Download: 37 Citations: 2

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Do Young Kim

Clin Mol Hepatol. 2022;28(4):939-939. Published online June 24, 2022

DOI: https://doi.org/10.3350/cmh.2021.0277.e1
Corrects: Clin Mol Hepatol 2021;27(4):620

View: 1253 Download: 27

Viewed By 5617	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3585	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3261	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2718	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2612	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology

Cited By 88	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 33	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Topics